# Determination of Absorption and Elimination of Lamotrigine-XR

> **NCT00789113** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 12 (actual)

## Conditions studied

- Epilepsy
- Seizures
- Bipolar Disorder
- Bipolar Depression

## Interventions

- **DRUG:** Extended Release Lamotrigine

## Key facts

- **NCT ID:** NCT00789113
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00789113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00789113, "Determination of Absorption and Elimination of Lamotrigine-XR". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00789113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*